We are live on ! Find out more
GC

Gratus Capital Portfolio holdings

AUM $2.5B
1-Year Est. Return 32.89%
This Fund
S&P 500
This Quarter Est. Return
+13.19%
1 Year Est. Return
+32.89%
3 Year Est. Return
+51.43%
5 Year Est. Return
+136.95%
10 Year Est. Return
–
AUM
$747M
AUM Growth
+$108M
Cap. Flow
+$34.4M
Cap. Flow %
4.61%
Top 10 Hldgs %
25.43%
Holding
196
New
28
Increased
69
Reduced
61
Closed
13

Top Buys

Rank Stock Value
1
LYB icon
LyondellBasell Industries
LYB
+$9.32M
2
T icon
AT&T
T
+$7.8M
3
DGRO icon
iShares Core Dividend Growth ETF
DGRO
+$7.54M
4
GILD icon
Gilead Sciences
GILD
+$7.53M
5
VTIP icon
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
+$7.35M

Top Sells

Rank Stock Value
1
QLTA icon
iShares AAA-A Rated Corporate Bond ETF
QLTA
+$8.88M
2
AZN icon
AstraZeneca
AZN
+$6.84M
3
CSCO icon
Cisco
CSCO
+$6.71M
4
CTXS
Citrix Systems Inc
CTXS
+$6.04M
5
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$6.01M

Sector Composition

Rank Sector Weight
1 Technology 16.72%
2 Healthcare 11.36%
3 Financials 10.51%
4 Consumer Discretionary 8.84%
5 Industrials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTG icon
176
Entegris
ENTG
$21.9B
$202K 0.03%
+2,100
New +$183K
CF icon
177
CF Industries
CF
$18.1B
$201K 0.03%
+5,195
New +$171K
RES icon
178
RPC Inc
RES
$1.31B
$179K 0.02%
56,723
– –
MPX
179
DELISTED
Marine Products Corp
MPX
$153K 0.02%
10,549
– –
STRM
180
DELISTED
Streamline Health Solutions
STRM
$142K 0.02%
6,054
– –
VNOM icon
181
Viper Energy
VNOM
$8.3B
$127K 0.02%
10,945
– –
RDI icon
182
Reading International Class A
RDI
$32.7M
$79K 0.01%
15,768
-200
-1% -$698
PAVM icon
183
PAVmed
PAVM
$37.9M
$23K ﹤0.01%
24
– –
AMRN
184
CALL
Amarin Corp
AMRN
$299M
– –
-30
Closed -$2K
AZN icon
185
AstraZeneca
AZN
$242B
– –
-62,376
Closed -$6.84M
BHP icon
186
BHP
BHP
$223B
– –
-130,190
Closed -$6M
FLGT icon
187
Fulgent Genetics
FLGT
$533M
– –
-10,000
Closed -$400K
FNV icon
188
Franco-Nevada
FNV
$42.6B
– –
-7,000
Closed -$977K
CYPH
189
Cypherpunk Technologies Inc
CYPH
$73.1M
– –
-2,500
Closed -$50K
SHM icon
190
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
– –
-4,040
Closed -$201K
ZM icon
191
Zoom
ZM
$29.9B
– –
-455
Closed -$214K
ZYME icon
192
Zymeworks
ZYME
$1.67B
– –
-10,000
Closed -$466K
ETRN
193
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
– –
-710,311
Closed -$6.01M
ISEE
194
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-50,000
Closed -$282K
CTXS
195
DELISTED
Citrix Systems Inc
CTXS
– –
-43,876
Closed -$6.04M
XLNX
196
DELISTED
Xilinx Inc
XLNX
– –
-50,819
Closed -$5.3M
4 5 6 7
8

Similar funds

LFDLE
La Financiere de L'Echiquier Paris, France $2.29B AUM 37.29% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
AT
Arvest Trust Bartlesville, Oklahoma $1.68B AUM 14.24% 1-Year Est. Return
BPCA
Bank Pictet & Cie (Asia) Singapore $1.57B AUM 25.56% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return

Gratus Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Gratus Capital held 196 positions worth $747M, up 17% from $639M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Gratus Capital deployed $34.4M of net new capital in Q4 2020, opening 28 new positions and adding to 69 existing holdings. Its largest new stake was LyondellBasell Industries: 114,357 shares worth $10.5M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares AAA-A Rated Corporate Bond ETF, an estimated $8.88M trimmed.

  • Gratus Capital's largest Q4 2020 buy was LyondellBasell Industries: 114,357 shares worth $10.5M.
  • Gratus Capital added most to AT&T in Q4 2020, an estimated $7.8M increase.
  • Gratus Capital's biggest Q4 2020 reduction was iShares AAA-A Rated Corporate Bond ETF, cutting an estimated $8.88M.
  • Gratus Capital fully exited AstraZeneca in Q4 2020, selling an estimated $6.84M.
  • Gratus Capital's ten largest holdings make up 25% of its $747M portfolio in Q4 2020.
  • Gratus Capital opened 28 new positions and closed 13 in Q4 2020.
  • Gratus Capital's portfolio value rose 17% quarter-over-quarter to $747M.

Based on Gratus Capital's 13F filing for Q4 2020, filed 3 Feb 2021.